The latest science on anthocyanins and their use in nutraceutical applications

Overview

Anthocyanins, which are most concentrated in berries such as bilberries and blackcurrants, represent one of the most promising areas of nutritional research for cardiovascular health.

Their ability to have a potent and consistent effect on cholesterol levels, blood flow and platelet activity makes anthocyanins an attractive ingredient for use in dietary supplements and functional foods.

In addition to reviewing the latest clinical evidence on anthocyanins, this webinar will provide case studies on the use of one highly potent, naturally sourced health ingredient, and a final dosage form.

Experts featuring this session

Dr. Laura Headley
Nutritional Scientist
Vita

Dr. Headley is a Nutritional Scientist at Evonik where she leverages her scientific and nutraceutical expertise to support the development of advanced food ingredients and co-ordinate related clinical trials.

Before joining Evonik in 2018, she was a registered Dietitian and Nutritional Scientist for more than 13 years.

She earned a PhD from the University of Surrey, Guildford, UK in the field of human nutrition and cardiovascular disease, followed by several years as a Post-Doctoral Research Fellow, where she gained extensive experience in the planning, management and reporting of nutrition-focused clinical trials.

Susanne Pluta
Director Consumer Products
Vita

Ms. Pluta joined Evonik in 2019 as the director of consumer products for Evonik’s Health Care business line.

In her current role, she is responsible for Evonik’s nutraceutical brand Medox and related consumer product business in German speaking countries.

Prior to joining Evonik, she held several senior roles at Bayer AG relating to the marketing, business intelligence and purchasing of nutraceutical products.

She has also been responsible for the marketing and launch of various OTC-products, dietic foods and other healthcare products for companies including Sandoz, Merck and IHS GmbH.